<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener("load", function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <iframe src="http://www.blogger.com/navbar.g?targetBlogID=6223270&amp;blogName=James+Hatton+on+licensing&amp;publishMode=PUBLISH_MODE_FTP&amp;navbarType=BLUE&amp;layoutType=CLASSIC&amp;homepageUrl=http%3A%2F%2Fwww.jameshatton.com%2Fpublic%2F&amp;blogLocale=en_CA&amp;searchRoot=http%3A%2F%2Fblogsearch.google.com%2F" marginwidth="0" marginheight="0" scrolling="no" frameborder="0" height="30px" width="100%" id="navbar-iframe" title="Blogger Navigation and Search"></iframe> <div></div>

Tuesday, January 31, 2006

"Biotech Licensing Deals: Greater Risk, But Greater Reward?"

From the April '05 KPMG Pharmaceuticals Insider Focus.

The tone is captured here: "As drug pipelines dwindle and blockbuster drug patents expire, the demand for new treatments has skyrocketed. At the same time, the industry's maturation has made biotech firms smarter in how they structure deals."

Short on specifics, but maybe they shouldn't have quoted me so much...

10:12 AM

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home